Bio-Techne (NASDAQ:TECH) is preparing to release its quarterly earnings on Wednesday, 2026-02-04. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Bio-Techne Corporation TECH is set to release second-quarter fiscal 2026 results on Feb. 4, before the opening bell. The life science and diagnostic product maker posted adjusted earnings per share ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at research tools & consumables stocks, ...

Bio-Techne beat estimated earnings by 15.0%, reporting an EPS of $0.46 versus an estimate of $0.4. Revenue was down $1.15 million from the same period last year. Last quarter the company beat on EPS ...

Use of Non-GAAP Financial Measures: This press release contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). We ...

CEO Kim Kelderman reported that "our second quarter performance was largely in line with our expectations. Continued strength from our large pharma customers was offset by a soft yet improving biotech ...

Bio-Techne (TECH) has expanded its COMET spatial biology platform with new SPYRE Focus Panels, SPYRE Amplification Kits, and updated HORIZON image analysis tools, a product move that matters for the ...

It has been about a month since the last earnings report for Techne (TECH). Shares have lost about 15.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...